甲状腺乳头状微小癌中央组淋巴结清扫的临床意义(3)
 |
| 第1页 |
参见附件。
[9]Chow TL, Lim BH, Kwok SP. Sentinel lymph node dissection in papillary thyroid carcinoma. ANZ J Surg, 2004,74(1-2),10-12.
[10]Chen FJ, Li QL, Zeng ZY, et al. Surgical treatment of differentiated thyroid carcinoma and analysis of recurrence-related factors. Ai Zheng, 2004,23(11);1311-1316.
[11]Pelize MR, Boschin IM, Toniato A, et al. Papillary thyroid microcarcinoma (PTMC): prognostic factors management and outcome in 403 patients [J]. Eur J Surg Oncol, 2006, 32 (10): 1144-1148.
[12]Borel AL, Boizel R, Fame P, et a1. Significance of low levels of thyroglobulin in fine needle aspirates from cervical lymph nodes of patients with a history of differentiated thyroid cancer, Eur J Endocrinol. 2008,158: 691-698.
[13]李智，乳頭状甲状腺癌淋巴结转移特点与中央组淋巴结清扫的临床意义，中华外科杂志，2008,9月，第46卷，18期。
[14]杨春明.甲状腺癌诊断和治疗的进展.中国现代普通外科进展，1999，2(1)：1-6.
[15]Ito Y, Tomoda C, Uruno T, et a1. Clinical significance of metastasis to the central compartment from papillary microcarcinoma of the thyroid [J]. World J Surg, 2006, 30(1): 91-99.
[16]王家东，裘行敏，周梁，等.分化型甲状腺微小癌45例报告[J].临床耳鼻咽喉科杂志，2001，15(12)：542—543。
[17]张益红,于秋凤，苗朝良，54.例甲状腺癌患者术中前哨淋巴结检测结果分析[J]。山东医药,2008;48(8),117。
[18]狄忠民.甲状腺微小癌诊断和治疗：附52例报告.中国普通外科杂志，2008，20(11)：358-359.
您现在查看是摘要介绍页，详见PDF附件。